Table 3.
Unadjusted rates of primary and secondary outcomes
| Campus | East | West | ||||
|---|---|---|---|---|---|---|
| Study Phase | Baseline (n=3,747) |
Intervention (n=6,191) |
p-value* | Baseline (n=11,177) |
Intervention (n=5,285) |
p-value* |
| Outcome | ||||||
| Any “inappropriate” acid-suppressive exposure† | 4.0% | 0.6% | <0.001 | 7.7% | 2.2% | <0.001 |
| Any acid-suppressive exposure | 33.1% | 31.8% | 0.16 | 54.5% | 52.9% | 0.05 |
| Discharged on acid-suppressive medication | 18.9% | 19.6% | 0.40 | 34.7% | 34.7% | 0.95 |
*
Fisher’s Exact test
†
Defined as an admission with at least 1order for acid-suppressive medication with stress ulcer prophylaxis as the only recorded indication in a patient located outside of the ICU.